Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer...
11 KB (806 words) - 05:38, 27 May 2024
In cases of severe bleeding, it can be reversed with the antidote, idarucizumab. Use is not recommended during pregnancy or breastfeeding. Compared to...
41 KB (3,733 words) - 19:42, 20 September 2024
idarucizumab (for dabigatran) and andexanet alfa (for factor Xa inhibitor) have been used in clinical settings with varying efficacy. Idarucizumab is...
78 KB (8,755 words) - 15:35, 24 September 2024
intracerebral bleeding on antiplatelet medication. The specific reversal agents idarucizumab and andexanet alfa may be used to stop continued intracerebral hemorrhage...
44 KB (4,483 words) - 17:27, 12 September 2024
agents for antithrombotic drugs Andexanet alfa Ciraparantag Vitamin K Idarucizumab "Specialist Pharmacy Service: Bentracimab". National Health Service....
4 KB (200 words) - 00:21, 29 January 2023
oxygen therapy (HBOT) Carbon monoxide poisoning and cyanide poisoning Idarucizumab Reversal of dabigatran etexilate, an anticoagulant Insulin + Glucagon...
8 KB (523 words) - 11:51, 18 May 2024
III Empagliflozin SGLT-2-inhibitor Diabetes mellitus type II Approved Idarucizumab Humanized antibody fragment (FAB), specific reversal agent to dabigatran...
40 KB (3,324 words) - 23:21, 18 September 2024
100 mg vial) which is higher than reversal agents for other DOAC agents (idarucizumab for use in dabigatran reversal is $4,200 per reversal). "Andexxa APMDS"...
16 KB (1,367 words) - 05:19, 9 October 2024
connected with a piperazine containing linker chain. Andexanet alfa Idarucizumab Prothrombin complex concentrate Vitamin K Schubert-Zsilavecz M, Wurglics...
6 KB (317 words) - 13:25, 3 December 2023
Complementing these drugs are reversal agents available for dabigatran (idarucizumab), and for apixaban, and rivaroxaban (andexanet alfa). Andexanet alfa...
94 KB (9,799 words) - 17:53, 8 October 2024
CD20 Y non-Hodgkin's lymphoma Icrucumab mab human VEGFR-1 cancer etc. Idarucizumab Praxbind mab humanized dabigatran Y reversal of anticoagulant effects...
136 KB (4,079 words) - 00:12, 12 October 2024
Hydroxocobalamin V03AB34 Fomepizole V03AB35 Sugammadex V03AB36 Phentolamine V03AB37 Idarucizumab V03AB38 Andexanet alfa V03AB54 Pralidoxime and atropine QV03AB90 Atipamezole...
3 KB (373 words) - 00:33, 26 December 2023
PDL-1 positive NSCLC Nivolumab Bristol-Myers Squibb metastatic NSCLC Idarucizumab Boehringer Ingelheim reversal of dabigatran Asfotase alfa Alexion Pharmaceuticals...
34 KB (180 words) - 22:09, 8 April 2024
follicular, or transformed B-cell non-Hodgkin's lymphoma 125019 Link idarucizumab Praxbind Boehringer Ingelheim 10/16/2015 intravenous humanized Fab dabigatran...
58 KB (4,072 words) - 19:33, 11 October 2024
2020). "Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort". Neurology. doi:10.1212/WNL.0000000000009155. ISSN 1526-632X...
6 KB (692 words) - 04:03, 8 March 2024